http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#Head http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#assertion http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#provenance http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#pubinfo http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#assertion http://purl.obolibrary.org/obo/DOID_1558 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1558 http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB14209 http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association http://www.w3.org/2000/01/rdf-schema#label "Trandolapril tablets are contraindicated in patients who are hypersensitive to this product, in patients with hereditary/idiopathic angioedema and in patients with a history of angioedema related to previous treatment with an ACE inhibitor. Do not co-administer aliskiren with trandolapril in patients with diabetes (see PRECAUTIONS, Drug Interactions Trandolapril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer trandolapril tablets within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see WARNINGS" http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB14209 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#provenance http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#pubinfo http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#sig http://purl.org/nanopub/x/hasSignature KqbwjYH2U/Rh2leW3QeQZWMiuN1bWjM+pbnr7JCU0Xwu+HHpf1UnVfGMyh/clYtMPx+AMMTUDOVwnGmGmvv676OO0LgjDvLj03Wq6rl4zpVdWeoFCp7MWMI2HMnF0f8AGXSPGKv6pHt/P2imxErJ0nLuLx+RYp8fYQcpI4Phhl8= http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg http://purl.org/dc/terms/created 2021-08-25T13:54:45.572+02:00 http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY